Ozempic frequently causes nausea, vomiting, and reduced appetiteeffects that are central to its therapeutic action but may lead to inadequate fluid and food intake
Addition of liraglutide in patients with type 2 diabetes well controlled on metformin monotherapy improves several markers of vascular function
The reported events include severe nausea, vomiting, diarrhea, and abdominal pain, symptoms that overlap with known GLP-1 side effects but may also reflect dosing errors or product quality issues
It is a prescription medication with real medical considerations and should not be taken without proper medical guidance
At 28.5 billion CFUs upon manufacture (at least 15 billion CFUs upon expiration), our capsules contain 5 strains that were carefully selected for their potential to aid in weight loss, fat tissue mass reduction, and maintenance of intestinal health